You are here

  • Home
  • Archive
  • Volume 16, Issue 1
  • Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline CHEK2 mutation

Citation Tools

Article menu
Download PDFPDF
Case Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline CHEK2 mutation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Berger BT, Labriola MK, Antonarakis ES, et al
Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline CHEK2 mutation
BMJ Case Reports CP 2023;16:e251320.